Lumea, a U.S. leader in digital pathology and clinical diagnostic solutions, today announced the integration of Nonagen Bioscience’s Oncuria® suite of bladder cancer tests into Lumea’s comprehensive digital diagnostics platform….
How do you answer one of the most consequential questions in cancer care: not just whether a patient has cancer, but which treatment will actually help them? For years, the…
Minnesota Urology is one of the largest urology practices in the upper Midwest. Headquartered in the Twin Cities area, the group specializes in adult urology care for patients throughout Minnesota…
Revolutionary sponge-fixation transport system recognized for modernizing prostate cancer diagnostics and preserving tissue integrity. LEHI, UT, UNITED STATES, September 8, 2026 — Lumea today announced its BxBoard® biopsy transportation and…
LEHI, UT, UNITED STATES, September 1, 2026 – Lumea, a U.S. leader in digital pathology solutions, and TreatmentGPS, a physician-built AI platform for clinical decision support and patient education, today…
Abigail Diepeveen Senior Director of Growth & Digital Strategy Abigail Diepeveen is Senior Director of Growth & Digital Strategy at Lumea, where she has spent nearly a decade working at…
The 2026 Digital Diagnostic Summit begins Wednesday, August 26, at the St Regis Resort in Park City, Utah! This exclusive conference focuses on “Mapping Diagnostic Innovation to Patient Impact”. Together,…
The decision to implement digital pathology is easier than the implementation itself. Labs that approach the transition without a structured plan often find themselves managing dual workflows longer than expected,…
Company Recognized for Large Revenue Growth, Earning a Place Among the Nation’s Most Successful Independent Businesses LEHI, UT, UNITED STATES, August 11, 2026 /EINPresswire/ — Lumea today announced it has…
For years, the promise of digital pathology was simple: move the glass to a monitor and everything speeds up. The reality turned out to be much more complicated. Some of…
